within Pharmacolibrary.Drugs.ATC.G;

model G04CB01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.8,
    Cl             = 0.000135,
    adminDuration  = 600,
    adminMass      = 5 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.076,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.01,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>G04CB01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Finasteride is a synthetic 4-azasteroid and a competitive inhibitor of type II 5-alpha-reductase, the enzyme that converts testosterone to dihydrotestosterone (DHT). It is used primarily for the treatment of benign prostatic hyperplasia (BPH) in men and male pattern hair loss (androgenetic alopecia). Finasteride is an FDA-approved, widely used oral medication.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics reported for healthy adult male volunteers following single oral administration.</p><h4>References</h4><ol><li><p>Gupta, AK, Talukder, M, &amp; Williams, G (2022). Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia. <i>The Journal of dermatological treatment</i> 33(7) 2946–2962. DOI:<a href=\"https://doi.org/10.1080/09546634.2022.2109567\">10.1080/09546634.2022.2109567</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/35920739/\">https://pubmed.ncbi.nlm.nih.gov/35920739</a></p></li><li><p>Gupta, AK, Talukder, M, &amp; Shemer, A (2024). Efficacy and safety of low-dose oral minoxidil in the management of androgenetic alopecia. <i>Expert opinion on pharmacotherapy</i> 25(2) 139–147. DOI:<a href=\"https://doi.org/10.1080/14656566.2024.2314087\">10.1080/14656566.2024.2314087</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/38315101/\">https://pubmed.ncbi.nlm.nih.gov/38315101</a></p></li><li><p>McClellan, KJ, &amp; Markham, A (1999). Finasteride: a review of its use in male pattern hair loss. <i>Drugs</i> 57(1) 111–126. DOI:<a href=\"https://doi.org/10.2165/00003495-199957010-00014\">10.2165/00003495-199957010-00014</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/9951956/\">https://pubmed.ncbi.nlm.nih.gov/9951956</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end G04CB01;
